To validate the biological significance of the mRNA expression analysis, we performed preliminary Western blot experiments for the investigation of the protein levels of TGM2, BCL2, and LC3B in two lower-risk patients and two higher-risk MDS patients as well as in three healthy individuals. This evidence concerns the gene TGM2 and myelodysplastic syndrome.